Q2 2019 Holdings
Filed 2019-08-12 | 12 holdings | $127.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cardlytics, Inc.(CDLX) | Common Stock | 14161W105 | $59.2K | 2,277,342 | 46.5% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $29.9K | 1,473,186 | 23.5% |
| Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | $11.9K | 1,857,582 | 9.3% |
| Neuronetics, Inc.(STIM) | Common Stock | 64131A105 | $9.3K | 742,289 | 7.3% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $5.0K | 2,773,479 | 3.9% |
| x4 Pharmaceuticals Inc(ASNSUSD) | Common Stock | 98420X103 | $4.7K | 311,492 | 3.7% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $3.1K | 1,841,924 | 2.4% |
| Trevena, Inc. | Common Stock | 89532E109 | $2.1K | 2,053,540 | 1.7% |
| Genocea Biosciences, Inc.(GNCAQ) | Common Stock | 372427401 | $965 | 246,078 | 0.8% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $670 | 130,571 | 0.5% |
| Pulmatrix, Inc. | Common Stock | 74584P202 | $331 | 359,438 | 0.3% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $277 | 326,243 | 0.2% |